Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment and Improve the Competitiveness of Japanese Players Japan’s pharmaceutical industry is the second largest in the world, worth over $89 billion or approximately 10% of the world market. Growth of the domestic pharmaceutical industry has recently been hampered by biennial drug price reductions, whichContinue reading “Japan Pharmaceutical Market Outlook”